Results 211 to 220 of about 1,457,300 (387)

Heterogeneity of Rheumatoid Arthritis–Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations With Disease Outcomes

Arthritis Care &Research, EarlyView.
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999 to 2021.
Bryant R. England, Yangyuna Yang, Punyasha Roul, Tate M. Johnson, Scott M. Matson, Grant W. Cannon, Brian C. Sauer, Jeffrey R. Curtis, Joshua F. Baker, Ted R. Mikuls   +9 more
wiley   +1 more source

Supplementum 289: Abstracts of the of the annual meeting of the Swiss Society of Allergology and Immunology (Lausanne, Switzerland, August 28-29, 2025)

Swiss Medical Weekly
Swiss Society of Allergology and Immunology
doaj   +1 more source

Deciphering Sjögren's disease: New insights and perspectives extend from advanced omics approaches and immunology

Hu Chen, Naoki Kaneko, Yukiko Ohyama, Masafumi Moriyama   +3 more
openalex   +1 more source

Book Review: Cellular Immunology [PDF]

, 1982
Marc Feldmann
openalex   +1 more source

Genetics, Epigenetics, Cellular Immunology, and Gut Microbiota: Emerging Links With Graves’ Disease

, 2022
Fangyu Zhou, Xin Wang, Lingjun Wang, Xin Sun, Guiqin Tan, Wenwen Wei, Guangbing Zheng, Xiaomin Ma, Dan Tian, Hongsong Yu   +9 more
openalex   +1 more source

Serum Uric Acid Levels in Older Adults: Associations With Clinical Outcomes and Implications for Reference Intervals in Those Aged 70 Years and Over

Arthritis Care &Research, EarlyView.
Objective Reports have linked both high and low serum uric acid (SUA) levels to adverse health outcomes. This study aimed to establish a reference interval for SUA in older adults and assessed its association with clinically relevant outcomes in relatively healthy, community‐dwelling individuals aged ≥70 years old.
Amanda J. Rickard, Cammie Tran, Hans G. Schneider, Flavia M. Cicuttini, Anita E. Wluka, Ego Seeman, Johannes T. Neumann, Md Nazmul Karim, Zhen Zhou, Sultana Monira Hussain, David P. Q. Clark, Daniel Clayton‐Chubb, Andrew M. Tonkin, Lawrence J. Beilin, Robyn L. Woods, John J. McNeil   +15 more
wiley   +1 more source

Immunological Tolerance [PDF]

Frontiers in Immunology, 2010
Boehmer, Harald von, Waldmann, Herman
openaire   +2 more sources

Correction: Neutrophils as key drivers of pulmonary fibrosis: unveiling mechanisms and therapeutic implications. [PDF]

Front Immunol
Liang X, Li Y, Tang Z, Luo Y, Liu Y.
europepmc   +1 more source

Long‐Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration

Arthritis Care &Research, EarlyView.
Objective Though used frequently to treat flare, risk of long‐term opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed long‐term opioids over time.
Lindsay N. Helget, Bryant R. England, Punyasha Roul, Harlan Sayles, Tuhina Neogi, James R. O'Dell, Joshua F. Baker, Ted R. Mikuls   +7 more
wiley   +1 more source

Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies

, 2022
Sara Sánchez-Molina, Elisabet Figuerola-Bou, Víctor Sánchez‐Margalet, Luis de la Cruz‐Merino, Jaume Mora, Enrique de Álava, Daniel J. García-Domínguez, Lourdes Hontecillas‐Prieto   +7 more
openalex   +1 more source